Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 423.53 | 337.65 | 247.51 | 302.16 |
Depreciation/ Depletion | 74.27 | 51.85 | 44.78 | 36.15 |
Non- Cash Items | -18.85 | 22.39 | -9.47 | 42.13 |
Changesin Working Capital | -248.54 | -174.48 | -183.56 | -201.71 |
Cashfrom Operating Activities | 230.41 | 237.41 | 99.26 | 178.74 |
Capital Expenditures | -208.84 | -53.63 | -46.33 | -46.42 |
Other Investing Cash Flow Items Total | 68.00 | -205.58 | -38.06 | 1.53 |
Cashfrom Investing Activities | -140.84 | -259.21 | -84.39 | -44.90 |
Financing Cash Flow Items | -5.17 | -6.07 | -4.22 | -7.99 |
Total Cash Dividends Paid | -22.66 | -10.17 | -10.58 | -4.09 |
Issuance( Retirement)of Stock Net | 0.00 | 229.54 | 91.16 | - |
Issuance( Retirement)of Debt Net | -40.90 | -15.48 | 3.16 | -3.21 |
Cashfrom Financing Activities | -68.73 | 197.83 | 79.51 | -15.29 |
Foreign Exchange Effects | 0.00 | 0.00 | 0.00 | - |
Net Changein Cash | 20.84 | 176.03 | 94.38 | 118.56 |
Cash Interest Paid | 5.17 | 6.07 | 4.22 | 7.99 |
Cash Taxes Paid | 122.35 | 63.01 | 72.86 | 48.53 |
Marksans Pharma Dividend Marksans Pharma Bonus Marksans Pharma News Marksans Pharma AGM Marksans Pharma Rights Marksans Pharma Splits Marksans Pharma Board Meetings Marksans Pharma Key Metrics Marksans Pharma Shareholdings Marksans Pharma Profit Loss Marksans Pharma Balance Sheet Marksans Pharma Q1 Results Marksans Pharma Q2 Results Marksans Pharma Q3 Results Marksans Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks